Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation (STP-LYM-01)

This study has been terminated.
(Recruitment delayed, trial medication no loner available)
Information provided by (Responsible Party):
Technische Universität München Identifier:
First received: June 4, 2010
Last updated: April 25, 2016
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):